UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042541
Receipt number R000048557
Scientific Title Efficacy of Bilevel-auto CPAP treatment after switching from Auto-CPAP treatment in OSA patients
Date of disclosure of the study information 2021/01/01
Last modified on 2022/05/27 13:57:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Bilevel-auto CPAP treatment after switching from Auto-CPAP treatment in OSA patients

Acronym

Efficacy of Bilevel-auto CPAP treatment

Scientific Title

Efficacy of Bilevel-auto CPAP treatment after switching from Auto-CPAP treatment in OSA patients

Scientific Title:Acronym

Efficacy of Bilevel-auto CPAP treatment

Region

Japan


Condition

Condition

Sleep apnea syndrome

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the usefulness of Bilevel auto CPAP treatment for obstructive sleep apnea

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To compare the average usage time, average usage rate, and AHI for 1 months before and after switching from the conventional Auto CPAP to Bilevel auto CPAP mode.

Key secondary outcomes

To compare the average CPAP pressure, average leak time and %, apnea/hypopnea events, CSR% for 1 months before and after switching from the conventional Auto CPAP to Bilevel auto CPAP mode. To examine the characteristics of a group of patients who have been ineffective with conventional Auto CPAP treatment.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

2 months of CPAP treatment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)OSA patients with AHI 20 or greater at PSG
2)Patients who have been on CPAP treatment for more than 3 months
3) Patient after mask fitting
4) Patients who have received informed consent

Key exclusion criteria

1)Major uncontrolled medical or psychiatric conditions
2)chronic respiratory failure or insufficiency
3)Surgery on the upper airway, nose, sinus, or middle ear within 90 days of participation
4)Cases of severe rhinitis or sinusitis complications
5)The presence of any untreated and diagnosable non-OSA sleep disorder (e.g., restless legs syndrome, insomnia, PLMD)
6)Current shift workers
7)Known history of alcohol or drug abuse within the past3 years
8)Nocturia, cases of BPH and other urological diseases

Target sample size

200


Research contact person

Name of lead principal investigator

1st name KIMIMASA
Middle name
Last name SAITO

Organization

Mie Sleep Clinic

Division name

Depertment of Respiratory

Zip code

5190502

Address

446 sogo obata Ise,Mie

TEL

+81-596-29-1159

Email

k1saito@carrot.ocn.ne.jp


Public contact

Name of contact person

1st name KIMIMASA
Middle name
Last name SAITO

Organization

Medical corporation MSC

Division name

Mie Sleep Clinic

Zip code

5190502

Address

446 sogo obata Ise,Mie

TEL

+81-596-29-1159

Homepage URL


Email

k1saito@carrot.ocn.ne.jp


Sponsor or person

Institute

Medical corporation MSC
Mie Sleep Clinic

Institute

Department

Personal name



Funding Source

Organization

Medical corporation MSC

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical corporation MSC

Address

446 sogo obata Ise,MIe

Tel

+81-596-29-1159

Email

k1saito@carrot.ocn.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人MSC(三重県) 三重スリープクリニック(伊勢市)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2020 Year 11 Month 05 Day

Date of IRB

2020 Year 11 Month 18 Day

Anticipated trial start date

2020 Year 12 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 11 Month 24 Day

Last modified on

2022 Year 05 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048557


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name